ClinicalTrials.gg
Sign In

AIDS-related Kaposi sarcoma clinical trials

The registry lists 43 studies for AIDS-related Kaposi sarcoma across 9 countries. 2 are recruiting or about to start. 16 of them are mainly about AIDS-related Kaposi sarcoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the AIDS-related Kaposi sarcoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
30
Terminated
7
Withdrawn
3
Not yet recruiting
1
Recruiting
1
Status unknown
1

Phase

Phase 2
20
Phase 1
18
Phase 3
4

Where

United States
33
United Kingdom
1
Tanzania
1
Malawi
1
Brazil
1
Puerto Rico
1

Who runs them

National Cancer Institute (NCI) (12) · AIDS Malignancy Consortium (12) · Case Comprehensive Cancer Center (2) · Memorial Sloan Kettering Cancer Center (2) · Eastern Cooperative Oncology Group (2) · Roswell Park Cancer Institute (2) · National Institutes of Health Clinical Center (CC) (1) · Dana-Farber Cancer Institute (1)

What is being tested here

Drugs under test in AIDS-related Kaposi sarcoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Liposomal doxorubicin123
Doxorubicin123
Paclitaxel123
Nirogacestat102
Interleukin-12002
Etoposide002
Sunitinib002
Semaxinib002
Docetaxel002
Thalidomide002

Drug classes tested here Antimitotic agents 1 open · Tyrosine kinase inhibitors (TKIs) 5 · Angiogenesis inhibitors 5

Coming up

1phase 3 study under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 1 AIDS-related Kaposi sarcoma studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
100 (0%)0 (0%)
181 (100%)1 (100%)
301 (100%)1 (100%)
401 (100%)1 (100%)
501 (100%)1 (100%)
651 (100%)1 (100%)
751 (100%)1 (100%)
851 (100%)1 (100%)

Across all 43 studies, recruiting or not: 5% stop at 75 or younger and 2% at 65; 9% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.